Typhoid Vaccine

This page contains recent news articles, when available, and an overview of Typhoid Vaccine but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Background information on Typhoid Vaccine

[an error occurred while processing this directive]

News: Typhoid Vaccine



Crucell Nominates Cees de Jong as Management Board Member  -  Feb 11, 2008
CNNMoney.comCrucell also markets travel vaccines, such as the only oral anti-typhoid vaccine, an oral cholera vaccine and the only aluminum-free hepatitis A vaccine on

BUYINS.NET: CRZ, MSO, RAD, BUS, XNL, CRXL Have Been Removed From ...  -  Feb 6, 2008
Insurance News Net (press release),The company also markets various travel vaccines, such as Vivotif, the oral anti-typhoid vaccine; Dukoral, an oral cholera vaccine; and Epaxal,

How To Stay Healthy On Vacation  -  Jan 22, 2008
Forbes,...to prevent Hepatitis A and B. They also suggest a typhoid vaccine for people who have adventurous palates or plan to explore beyond the tourist areas.

Cephalexin: Drug Whys  -  Feb 4, 2008
EMS1.com - Emergency Medical Service Resources,Cephalexin also causes a decreased immune response to the oral live typhoid vaccine which should not be given until 24 hours after the last cephalexin dose.

Aeras and Crucell Announce Start of a Tuberculosis Vaccine ...  -  Dec 20, 2007
FOX NewsCrucell also markets travel vaccines, such as the only oral anti-typhoid vaccine, an oral cholera vaccine and the only aluminum-free hepatitis A vaccine on

Emergent Claims Vaccine Trial Success  -  Oct 10, 2007
Forbes,AP 10.10.07, 10:35 AM ET Emergent BioSolutions Inc. said Wednesday its single-dose, drinkable typhoid vaccine candidate showed positive results in a

Emergent BioSolutions moves forward with typhoid vaccine  -  Oct 11, 2007
BiopharmaReporter.com,By Katrina Megget 11/10/2007 - Emergent BioSolutions is on the path to finding gold with its typhoid vaccine following positive results in a Phase II trial.

Emergent BioSolutions’ Typhoid Vaccine Candidate Achieves ...  -  Oct 10, 2007
Business Wire (press release),...“We are very pleased to have met the objectives of this Phase II study of our typhoid vaccine candidate. This data is encouraging and indicates great

Emergent BioSolutions typhoid vaccine trial achieves endpoints  -  Oct 11, 2007
Pharmaceutical Business ReviewFuad El-Hibri, chairman and CEO, said: "We are very pleased to have met the objectives of this Phase II study of our typhoid vaccine candidate.

Emergent BioSolutions Reports Positive Results From Phase II Study ...  -  Oct 10, 2007
RTT News,The typhoid vaccine candidate is a live, attenuated strain of the Salmonella typhi bacterium designed to eliminate virulence by deletion of two specific

Emergent BioSolutions Says Its Typhoid Vaccine Candidate In Phase ...  -  Oct 10, 2007
RTT News,The preliminary results demonstrated that the company's drinkable typhoid vaccine candidate achieved the study endpoints for safety and immunogenicity.

BioSolutions posts healthy progress By Tom Ramstack  -  Oct 15, 2007
Washington Times,Last week, the company announced that a typhoid vaccine is showing positive results in Phase II clinical trials in a test on children in Vietnam.

Emergent BioSolutions’ Typhoid Candidate Achieves Endpoints in Trial  -  Oct 10, 2007
FDA news (subscription),Emergent BioSolutions reported its single-dose, drinkable typhoid vaccine candidate achieved the study endpoints for safety and immunogenicity.

Business briefs  -  Oct 11, 2007
Lansing State Journal,...operations based in Lansing, said Wednesday that it recently finished a phase II clinical study for its single-dose, drinkable typhoid vaccine.

PRESS RELEASE  -  Oct 14, 2007
CNNMoney.comCrucell also markets travel vaccines, such as the only oral anti-typhoid vaccine, an oral cholera vaccine and the only aluminium-free hepatitis A vaccine on

EBS: Appoints Dr. Stephen Lockhart to President of UK Product ...  -  Oct 18, 2007
Trading Markets (press release),These programs include, among others, the following product candidates: a single-dose oral typhoid vaccine that recently completed a Phase II clinical trial

ë³´ë?„ìž?료홈>ì „ì²´  -  Oct 16, 2007
한국경제 (보��료),The IVI, with the US National Institutes of Health, has also jointly developed a new typhoid vaccine that is safe and effective in infants.

Speak with other shareholders about:(NasdaqGM:CVTX)(OTC BB:SPKL)  -  Oct 3, 2007
TransWorldNews (press release),This segment?s product portfolio consists of Typhoid Vaccine, a single-dose drinkable vaccine in phase II clinical trial; Hepatitis B Therapeutic Vaccine,

Putting Typhoid Vaccination on the Global Health Agenda  -  Sep 12, 2007
New England Journal of Medicine (subscription),In those areas, a typhoid vaccine that can be given to infants through the WHO Expanded Program on Immunization would be ideal, once vaccines effective in

Many Scots unaware of typhoid vaccine, says new survey  -  Aug 29, 2007
The Herald,A new survey has revealed that many Scots are unaware there is a typhoid vaccine despite the number of people being struck down by the disease continuing to

Call for typhoid vaccine drive  -  Aug 29, 2007
Channel 4 News,People's knowledge of vaccines is poor, meaning diseases like typhoid are making a big comeback, health experts have revealed. An analysis of figures from

Crucell announces new STAR(R) technology research license in ...  -  Sep 6, 2007
CNNMoney.comCrucell also markets travel vaccines, such as the only oral anti-typhoid vaccine, an oral cholera vaccine and the only aluminium-free hepatitis A vaccine on

Emergent BioSolutions Inc. Q2 2007 Earnings Call Transcript  -  Aug 20, 2007
Seeking Alpha,An example of that is the typhoid vaccine. It's a single dose oral delivered product and candidate for patients who are going to be going into areas where

Don't forget about travel immunizations  -  Sep 11, 2007
SmarterTravel.com...to explore Maya ruins such as Tikal, an anti-malarial will be in order, and you'll probably want a Typhoid vaccine if you're going to Cambodia.

ThromboGenics Announces Successful Completion of Technology ...  -  Sep 3, 2007
ITNews,TYPBAR(TM) Vi Capsular Polysaccharide Typhoid vaccine, BIOGIT(TM) probiotic yeast, and INDIRAB(TM) anti-rabies vaccine. Bharat Biotech also has a strong

Russian Biologist Under Investigation  -  Sep 14, 2007
Washington Post,...to France in December to bring vials of a non-dangerous typhoid vaccine to colleagues when he was stopped by customs officials at Sheremyetevo Airport.

AVANT Starts Phase 2 Trials Of Typhoid Vaccine  -  Jul 31, 2007
Vaccine Rx (press release),AVANT Immunotherapeutics Inc., a Massachusetts-based biopharmaceutical company, began their Phase 2 testing of the oral typhoid fever vaccine, Ty800,

Pharma majors open new R&D chapter  -  Jun 27, 2007
Rediff,The partnership saved the company three to four years it would have needed to come up with its own typhoid vaccine, said KG Rajendran, R&D head at USV.

Carrington Subsidiary DelSite Predicts Preservative-Free Vaccines ...  -  Jun 25, 2007
PharmaLive.com (press release),...for a typhoid vaccine; and, with the National Cancer Institute, aimed at the development of a needle-free nasal powder delivery of future HPV vaccines.

DSM Biologics and Crucell Announce PER.C6 Licensing Deal With ...  -  05 Jun 2007
PharmaLive.com (press release),Crucell also markets travel vaccines, such as the only oral anti-typhoid vaccine, an oral cholera vaccine and the only aluminum-free hepatitis A vaccine on

Ondo LG bosses in N72m typhoid vaccine scam  -  May 21, 2007
Daily Sun,Under scrupulous interrogation, the 17 suspects admitted to have personally received the money specially dedicated to the typhoid vaccine project but did

Avant says typhoid vaccine promising  -  May 18, 2007
Boston Globe,Avant Immunotherapeutics Inc. said today that its typhoid fever vaccine candidate has demonstrated "excellent clinical potential."

Carrington enters pact with NIH for typhoid vaccine  -  May 17, 2007
Dallas Business Journal,Using NIH technology, the company plans to chemically modify its GelSite polymer into a new end-product that can be used as the vaccine antigen against

City paediatricians doubtful of vaccines not listed in UIP  -  May 26, 2007
Chandigarh Newsline,...“Typhoid vaccine available in the market has an efficacy of 50-70 per cent. Even though it has to be repeated every three years, it is worth taking,� Dr

Carrington Laboratories, Inc (Nasdaq: CARN) Subsidiary DelSite ...  -  May 17, 2007
PR Newswire (press release),Combination of NIH Technology and GelSite(R) Polymer Could Make Final Typhoid Vaccine Product More Cost Effective and Affordable IRVING, Texas,

Carrington Subsidiary Inks Deal With NIH  -  May 17, 2007
Forbes,It plans on using technology from NIH to develop a typhoid vaccine with the company's GelSite polymer, which it is developing as a method of

Health warnings for travellers to Fiji and Japan  -  27 Apr 2007
Waikato Times,..."Travellers heading to the island of Vanua Levu should consider being immunised with a hepatitis A and typhoid vaccine and speak to their GP for further

Crucell Announces PER.C6(R) Licensing Agreement  -  27 Apr 2007
SYS-CON Media,Crucell also markets travel vaccines, such as the only oral anti-typhoid vaccine, an oral cholera vaccine and the only aluminum-free hepatitis A vaccine on

Yalies in China  -  Apr 13, 2007
Yale Daily News,Eschewing a Yale-organized trip to regions of China that test your typhoid vaccine, Chris Schmicker ’08, one of last semester’s Yale-PKU participants,

DSM Biologics and Crucell Announce PER.C6 Licensing Deal with ...  -  Mar 26, 2007
PharmaLive.com (press release),Crucell also markets travel vaccines, such as the only oral anti-typhoid vaccine, an oral cholera vaccine and the only aluminum-free hepatitis A vaccine on

DSM Biologics and Crucell Announce PER.C6(R) Licensing Deal with ...  -  Mar 25, 2007
Genetic Engineering News (press release),Crucell also markets travel vaccines, such as the only oral anti-typhoid vaccine, an oral cholera vaccine and the only aluminum-free hepatitis A vaccine on

Spring Break Countdown  -  Mar 7, 2007
University Daily Kansan,If you’re traveling to Asia, Africa, the Caribbean, Central America or South America, a typhoid vaccine ($52) is recommended. If you’re traveling to the

Emergent BioSolutions Remains Committed to Development of Enhanced ...  -  Feb 22, 2007
PharmaLive.com (press release),...globulin as well as a typhoid vaccine and hepatitis B therapeutic vaccine, both in Phase II trials, a group B strep vaccine and a chlamydia vaccine.

DSM And Crucell Announce Breakthrough In The Production Of  -  Feb 19, 2007
Chemical Online.com (press release),Crucell also markets travel vaccines, such as the only oral anti-typhoid vaccine, an oral cholera vaccine and the only aluminum-free hepatitis A vaccine on

Merck & Co., Inc. and Crucell Sign Cross-licensing Agreement on ...  -  Dec 27, 2006
Genetic Engineering News (press release),Crucell also markets travel vaccines, such as the only oral anti-typhoid vaccine, an oral cholera vaccine and the only aluminum-free hepatitis A vaccine on the ...

Wyeth kicks off CMO agreement with Crucell  -  Dec 20, 2006
In-PharmaTechnologist.com,...worth €39.4m, less than two months after also acquiring Florida-based Berna Products Corp, which gave them full control of the company's oral typhoid vaccine ...

Crucell strengthens vaccine portfolio with SBL purchase  -  Nov 28, 2006
OutSourcing-Pharma.com,...also recently acquired Florida-based Berna Products Corp (BPC) in October 2006, which gave them full control of the company's oral typhoid vaccine Vivotif. ...


Search the web for more resources on Typhoid Vaccine
 
Web health.mongabay.com





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.


COPYRIGHT 2006 MONGABAY.COM